From Name:
From Email:
To Name:
To Email:

Optional Message:

The new key player in head and neck cancer care

from Cure

The treatment landscape of head and neck cancer has changed significantly over the past year. With the approval of Keytruda (pembrolizumab) in August 2016 and Opdivo (nivolumab) in November 2016, immunotherapy has become a key player in patient care. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063